Tenorix 20 mg tablet contains tenoxicam, a non-steroidal anti-inflammatory drug (NSAID) that reduces pain and inflammation in joints and muscles. It works by blocking prostaglandin production, which are substances the body makes during inflammation.
There are 5 brands of Tenoxicam listed in Bangladesh. 3 of them have a lower unit price than Tenorix. The lowest listed price is Inoten 20 mg Tablet at ৳ 8.03 per unit.
What is Tenorix 20 mg Tablet?
Tenorix is a tablet containing tenoxicam 20 mg, a medicine from the NSAID group. It is used for symptomatic treatment of painful inflammatory and degenerative conditions of the musculoskeletal system. These include rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, and extra-articular disorders such as tendinitis, bursitis, and sprains. It is also used for acute gout. Tenoxicam works by reducing substances in the body that cause inflammation and pain. The doctor will decide if this medicine is suitable and will determine the dose and course of treatment.
Uses of Tenorix
Tenorix is used for symptomatic relief of pain and inflammation in conditions such as rheumatoid arthritis, osteoarthritis, arthrosis, and ankylosing spondylitis. It is also used for extra-articular disorders like tendinitis, bursitis, periarthritis of the shoulder or hip, strains, and sprains, and for acute gout. It is a non-steroidal anti-inflammatory drug (NSAID). The doctor decides whether it is appropriate for your condition.
How to use Tenorix
Tenorix is taken by mouth as a tablet. The dose and how often to take it are decided by your doctor, who will consider your condition and other factors. Always follow the doctor's instructions exactly. Do not change the dose or stop treatment without asking your doctor. If you miss a dose, ask your doctor or pharmacist what to do. Swallow the tablet with water, and ask your pharmacist if you have questions about how to take it.
Side effects of Tenorix
Like all medicines, Tenorix can cause side effects. Commonly reported effects include stomach and abdominal discomfort, indigestion, heartburn, nausea, dizziness, and headache. Less common effects include constipation. Most side effects are mild and temporary, but some people may need to stop treatment. If you experience severe stomach pain, black stools, or any unusual symptom, contact your doctor promptly. Ask your doctor or pharmacist for advice about side effects.
Safety and precautions
Before taking Tenorix, tell your doctor if you have or have had stomach or bowel problems such as gastritis, ulcers, or bleeding. Do not take it if you are allergic to tenoxicam or if aspirin or other NSAIDs cause asthma, rhinitis, or urticaria. Tell your doctor about kidney, liver, or heart conditions, and about all other medicines you take. Avoid use during the third trimester of pregnancy. Breastfeeding mothers should ask their doctor, as the medicine may pass into breast milk. The doctor will decide if it is suitable for you.
Frequently asked questions
How should Tenorix be taken?
Tenorix is taken by mouth as a tablet. The dose and how often you take it are decided by your doctor based on your condition. Follow your doctor's instructions exactly and do not change the dose without medical advice.
What is Tenorix used for and what kind of medicine is it?
Tenorix is a non-steroidal anti-inflammatory drug (NSAID) used for painful inflammatory and degenerative musculoskeletal conditions such as arthritis, tendinitis, bursitis, sprains, and acute gout. It helps relieve pain and inflammation. Your doctor will decide if it is right for you.
How should Tenorix be stored?
Store Tenorix below 30°C, protected from light and moisture. Keep it out of the reach of children. Do not use it after the expiry date. Ask your pharmacist if you are unsure about storage.
What is the price of Tenorix?
The listed price is ৳ 8.06. Ask your pharmacist about the current price and any available pack sizes.
Tenoxicam is indicated for the symptomatic treatment of the following painful inflammatory and degenerative disorders of the musculoskeletal system:
Rheumatoid arthritis.
Osteoarthritis.
Arthrosis.
Ankylosing spondylitis.
Extra-articular disorders, e.g. tendinitis, bursitis, periarthritis of the shoulders (shoulder-hand syndrome) or hips, strains, and sprains.
Acute gout.
Pharmacology
Tenoxicam is a non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic and antipyretic properties and it also inhibits platelet aggregation. Tenoxicam inhibits prostaglandin biosynthesis. In-vitro tests of leukocyte peroxidase suggest that tenoxicam may act as a scavenger for active oxygen at the site of inflammation. Tenoxicam is a potent in-vitro inhibitor of human metalloproteinases (stromelysin and collagenase), which induce cartilage breakdown. These pharmacological effects explain, at least in part, the therapeutic benefit of Tenoxicam in the treatment of painful inflammatory and degenerative disorders of the musculoskeletal system. Tenoxicam showed no mutagenic, carcinogenic or teratogenic effects in animals. As with other prostaglandin inhibitors, renal and gastrointestinal effects, increased incidence of dystocia and delayed parturition were observed in animal safety studies.
Dosage & Administration
Standard dosage: For all indications except acute gout, a daily dosage of 20 mg should be given at the same time of day.
In acute attacks of gout: The recommended dose for acute attacks of gout is 40 mg once daily for two days followed by 20 mg once daily for a further five days.
In the treatment of chronic disorders: The therapeutic effect of tenoxicam is evident early in treatment but there is a progressive increase in response over time. In chronic disorders, daily doses higher than 20 mg should be avoided since this would increase the frequency and intensity of unwanted reactions without significantly increasing efficacy. For patients needing long-term treatment, a reduction to a daily oral dose of 10 mg may be tried for maintenance.
Special dosage instructions: In principle, the above dosage recommendations also apply to elderly patients and to patients suffering from kidney or liver disease. Because of lack of clinical experience, no dosage recommendations have so far been established for children and adolescents.
Interaction
As in the case of other NSAIDs, salicylate displaces tenoxicam from protein-binding sites and increases clearance and volume of distribution of tenoxicam. Concurrent treatment with salicylate or other NSAIDs should be avoided because of increased risk of gastrointestinal undesirable reactions. The co-administration of some NSAIDs and methotrexate has been associated with reduced renal tubular secretion of methotrexate, higher plasma concentrations of methotrexate, and severe methotrexate toxicity. Therefore, caution should be exercised when Tenoxicam is administered concurrently with methotrexate. No clinically relevant interaction was found in the small number of patients receiving concomitant treatment with gold, penicillamine or probenecid. As Tenoxicam may decrease the renal clearance of lithium, their concomitant administration may lead to increased plasma levels and toxicity of lithium. The plasma levels of lithium should be closely monitored. As with NSAIDs in general, Tenoxicam should not be administered concurrently with K-sparing diuretics. There is a known interaction between these two classes of compounds, which may cause hyperkalemia and renal failure. No clinically significant interaction between Tenoxicam and furosemide was noted, but Tenoxicam attenuates the blood pressure-lowering effect of hydrochlorothiazide. As known from other NSAIDs, Tenoxicam might attenuate the antihypertensive effects of alpha-adrenergic blockers and ACE-inhibitors. No interactions have been reported between NSAIDs and centrally-acting alpha agonists or calcium channel blockers. There was no clinically relevant interaction when Tenoxicam was administered together with atenolol. During clinical trials no interaction was reported for patients treated concomitantly with digitalis products. Thus concurrent dosing of Tenoxicam and digoxin appears to be without major risk. No interaction has been found with concomitantly administered antacids, cimetidine, warfarin and phenprocoumon at the recommended dosages. The clinical effect of oral antidiabetic drugs (glibornuride, glibenclamide, tolbutamide) was likewise not modified by Tenoxicam. Nevertheless, careful monitoring is recommended when patients concomitantly receive anticoagulants or oral antidiabetic drugs. No clinically relevant interaction has been found between Tenoxicam and low molecular weight heparin.
Contraindications
Tenoxicam must not be administered to patients:
known to be hypersensitive to the drug;
in whom salicylates or other non-steroidal anti-inflammatory drugs (NSAIDs) induce symptoms of asthma, rhinitis, or urticaria;
suffering or having suffered from the disease of the upper gastrointestinal tract, such as gastritis, gastric and duodenal ulcer.
Side Effects
Based on clinical trials including large numbers of patients, Tenoxicam proved to be well tolerated in the recommended dose. Usually, the undesirable effects reported were mild and transient. In a small proportion of patients, the interruption of treatment due to undesirable effects was necessary. Local tolerance of Tenoxicam given parenterally was good. The following undesirable effects have been reported:
Frequency is greater than 1%-
Gastrointestinal tract: gastric, epigastric and abdominal discomfort, dyspepsia, heartburn, nausea.
Central nervous system: dizziness, headache.
Frequency less than 1%-
Gastrointestinal tract: constipation, diarrhea, stomatitis, gastritis, vomiting, ulcers, Gl-bleeding including hematemesis and melena.
Cardiovascular system: elevated blood pressure, mainly in patients treated with cardiovascular drugs.
Liver/Biliary tract: hepatitis.
Pregnancy & Lactation
NSAIDs have an inhibitory effect on prostaglandin synthesis and, when given during late pregnancy, may cause the closure of the fetal ductus arteriosus, prolong labor and delay parturition. Treatment during the third trimester of pregnancy should be avoided. Based on findings from single-dose administration, a very small amount (approximately 0.2%) of tenoxicam passes into breast milk. There is no evidence of adverse reactions in breast-fed infants of mothers taking Tenoxicam. Nevertheless, infants should be weaned or the drug discontinued.
Precautions & Warnings
NSAIDs inhibit renal prostaglandin synthesis and consequently may have an undesirable effect on renal hemodynamics and on salt and water balance. It is necessary to adequately monitor the patient with a special emphasis on cardiac and renal function (BUN, creatinine, development of edema, weight gain, etc.) when giving Tenoxicam to patients with conditions that could increase their risk of developing renal failure, such as pre-existing renal disease, impaired renal function in diabetics, hepatic cirrhosis, congestive heart failure, volume depletion or concomitant treatment with potentially nephrotoxic drugs, diuretics and corticosteroids. Tenoxicam inhibits platelet aggregation and may affect hemostasis. Tenoxicam has no significant influence on blood coagulation factors, coagulation time, prothrombin time or activated thromboplastin time. Patients having coagulation disorders or receiving drug therapy that interferes with hemostasis should, however, be carefully observed when Tenoxicam is administered. Any patient being treated with Tenoxicam who presents with symptoms of gastrointestinal disease should be closely monitored. If peptic ulceration or gastrointestinal bleeding occurs, Tenoxicam should be immediately withdrawn. If severe skin reactions (e.g. Lyell's or Stevens-Johnson syndrome) occur, the treatment should be discontinued immediately. Adverse eye findings have been reported with Tenoxicam. Thus ophthalmic evaluation is recommended for patients who develop visual disturbances. Because of the high plasma protein binding of tenoxicam, caution is required when plasma albumin levels are markedly reduced. In common with anti-inflammatory drugs, Tenoxicam may mask the usual signs of infection. Tenoxicam Tablets should not be given to patients who either dislike or do not tolerate milk products.
Overdose Effects
Although there is no experience of acute overdosage with Tenoxicam, it may be expected that the signs and symptoms mentioned under Undesirable effects would be more pronounced. Overdose should be countered by conventional measures to reduce absorption (e.g. gastrolavage and charcoal) and speed up elimination (e.g. cholestyramine).
Storage Conditions
Do not store above 30°C, protect from light & moisture. Keep out of the reach of children.
Alternative brands of Tenoxicam
Other brands with the same generic name, cheapest first.